Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,081 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation.
Schneider-Hohendorf T, Wünsch C, Falk S, Raposo C, Rubelt F, Mirebrahim H, Asgharian H, Schlecht U, Mattox D, Zhou W, Dawin E, Pawlitzki M, Lauks S, Jarius S, Wildemann B, Havla J, Kümpfel T, Schrot MC, Ringelstein M, Kraemer M, Schwake C, Schmitter T, Ayzenberg I, Fischer K, Meuth SG, Aktas O, Hümmert MW, Kretschmer JR, Trebst C, Kleffner I, Massey J, Muraro PA, Chen-Harris H, Gross CC, Klotz L, Wiendl H, Schwab N. Schneider-Hohendorf T, et al. Among authors: klotz l. Brain. 2024 Jul 18:awae244. doi: 10.1093/brain/awae244. Online ahead of print. Brain. 2024. PMID: 39021292
Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study).
Passoke S, Stern C, Häußler V, Kümpfel T, Havla J, Engels D, Jarius S, Wildemann B, Korporal-Kuhnke M, Senel M, Stellmann JP, Warnke C, Grothe M, Schülke R, Gingele S, Kretschmer JR, Klotz L, Walter A, Then Bergh F, Aktas O, Ringelstein M, Ayzenberg I, Schwake C, Kleiter I, Sperber PS, Rust R, Schindler P, Bellmann-Strobl J, Paul F, Kopp B, Trebst C, Hümmert MW; Neuromyelitis Optica Study Group (NEMOS). Passoke S, et al. Among authors: klotz l. J Neurol Neurosurg Psychiatry. 2024 Jul 30:jnnp-2024-333994. doi: 10.1136/jnnp-2024-333994. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 39084862 Free article.
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks.
Schwake C, Ladopoulos T, Häußler V, Kleiter I, Ringelstein M, Aktas O, Kümpfel T, Engels D, Havla J, Hümmert MW, Kretschmer JR, Tkachenko D, Trebst C, Ayroza Galvão Ribeiro Gomes AB, Pröbstel AK, Korporal-Kuhnke M, Wildemann B, Jarius S, Pul R, Pompsch M, Krämer M, Then Bergh F, Gödel C, Schwarz P, Kowarik MC, Rommer PS, Vardakas I, Senel M, Winkelmann A, Retzlaff N, Weber MS, Husseini L, Walter A, Schindler P, Bellmann-Strobl J, Paul F, Gold R, Ayzenberg I; Neuromyelitis Optica Study Group (NEMOS). Schwake C, et al. J Neurol Neurosurg Psychiatry. 2024 Nov 4:jnnp-2024-334863. doi: 10.1136/jnnp-2024-334863. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 39496464 Free article.
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision.
Nicolescu M, Häußler V, Paul F, Oertel FC, Schindler P, Strobl JB, Krumbholz M, Hümmert MW, Bütow F, Tkachenko D, Trebst C, Schubert C, Ayzenberg I, Schwake C, Pakeerathan T, Fischer K, Aktas O, Ringelstein M, Kraemer M, Warnke C, Grothe M, Kaste M, Angstwurm K, Kern P, Kleiter I, Rommer P, Winkelmann A, Walter A, Weber MS, Wickel J, Giglhuber K, Then Bergh F, Senel M, Tumani H, Vardakas I, Dawin E, Revie L, Klotz L, Korporal-Kuhnke M, Jarius S, Wildemann B, Gernert JA, Kümpfel T, Engels D, Havla J, Stolowy N, Stellmann JP; Neuromyelitis Optica Study Group (NEMOS). Nicolescu M, et al. Among authors: klotz l. J Neurol. 2024 Dec 21;272(1):86. doi: 10.1007/s00415-024-12803-5. J Neurol. 2024. PMID: 39708205
Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT.
Cortese M, Munger KL, Martínez-Lapiscina EH, Barro C, Edan G, Freedman MS, Hartung HP, Montalbán X, Foley FW, Penner IK, Hemmer B, Fox EJ, Schippling S, Wicklein EM, Kappos L, Kuhle J, Ascherio A; BENEFIT Study Group. Cortese M, et al. Neurology. 2020 May 5;94(18):e1950-e1960. doi: 10.1212/WNL.0000000000009371. Epub 2020 Apr 16. Neurology. 2020. PMID: 32300060 Free PMC article. Clinical Trial.
Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.
Trojano M, Butzkueven H, Kappos L, Wiendl H, Spelman T, Pellegrini F, Chen Y, Dong Q, Koendgen H, Belachew S; Tysabri® Observational Program (TOP) Investigators. Trojano M, et al. Mult Scler Relat Disord. 2018 Aug;24:11-19. doi: 10.1016/j.msard.2018.04.020. Epub 2018 May 2. Mult Scler Relat Disord. 2018. PMID: 29860197 Free article.
Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
Vermersch P, Granziera C, Mao-Draayer Y, Cutter G, Kalbus O, Staikov I, Dufek M, Saubadu S, Bejuit R, Truffinet P, Djukic B, Wallstroem E, Giovannoni G; Frexalimab Phase 2 Trial Group. Vermersch P, et al. N Engl J Med. 2024 Feb 15;390(7):589-600. doi: 10.1056/NEJMoa2309439. N Engl J Med. 2024. PMID: 38354138 Clinical Trial.
Erratum to "Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - A cluster-randomised controlled trial and mixed methods process evaluation" [Patient Educ Couns 125 (2024) 108293].
Rahn AC, Peper J, Köpke S, Antony G, Liethmann K, Vettorazzi E, Heesen C; DECIMS study group. Rahn AC, et al. Patient Educ Couns. 2025 Jan;130:108363. doi: 10.1016/j.pec.2024.108363. Epub 2024 Nov 13. Patient Educ Couns. 2025. PMID: 39536521 Free article. No abstract available.
1,081 results